Deficiency in CD22, a B Cell–specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
CD22 is a B cell–specific transmembrane glycoprotein that acts to dampen signals generated through the B cell antigen receptor (BCR): B cells from CD22-deficient mice give increased Ca2+ fluxes on BCR ligation. Here we show that this B cell hyperresponsiveness correlates with the development of autoantibodies. After the age of eight months, CD22-deficient mice developed high titers of serum IgG directed against double-stranded DNA; these antibodies were of multiclonal origin, somatically mutated, and high affinity. Increased titers of antibodies to cardiolipin and myeloperoxidase were also noted. The results demonstrate that a single gene defect exclusive to B lymphocytes is, without additional contrivance, sufficient to trigger autoantibody development in a large proportion of aging animals. Thus, CD22 might have evolved specifically to regulate B cell triggering thresholds for the avoidance of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S. A., & Dunn, A. R. (1995) · Cell · doi:10.1016/0092-8674(95)90171-x · Cited by 700
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.
Shlomchik, M., Mascelli, M., Shan, H., Radic, M. Z., Pisetsky, D., Marshak-Rothstein, A., & Weigert, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.265 · Cited by 666
A Role in B Cell Activation for CD22 and the Protein Tyrosine Phosphatase SHP
Doody, G. M., Justement, L. B., Delibrias, C. C., Matthews, R. J., Lin, J., Thomas, M. L., & Fearon, D. T. (1995) · Science · doi:10.1126/science.7618087 · Cited by 538
Hyperresponsive B Cells in CD22-Deficient Mice
O'Keefe, T. L., Williams, G. T., Davies, S. L., & Neuberger, M. S. (1996) · Science · doi:10.1126/science.274.5288.798 · Cited by 532
Self-citationBatista, F. D., & Neuberger, M. S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80580-4 · Cited by 481
Self-citationPolygenic control of susceptibility to murine systemic lupus erythematosus
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., & Wakeland, E. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90100-7 · Cited by 471
Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, T., & Yamamoto, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90126-4 · Cited by 470
Chan, V. W. F., Meng, F., Soriano, P., DeFranco, A. L., & Lowell, C. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80511-7 · Cited by 451
CD22 is a negative regulator of B-cell receptor signalling
Nitschke, L., Carsetti, R., Ocker, B., Köhler, G., & Lamers, M. C. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00057-1 · Cited by 442
Sato, S., Miller, A. S., Inaoki, M., Bock, C. B., Jansen, P. J., Tang, M. L. K., & Tedder, T. F. (1996) · Immunity · doi:10.1016/s1074-7613(00)80270-8 · Cited by 434
Cornall, R. J., Cyster, J. G., Hibbs, M. L., Dunn, A. R., Otipoby, K. L., Clark, E. A., & Goodnow, C. C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80554-3 · Cited by 428
Fearon, D. T. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1971 · Cited by 418
CD22 regulates thymus-independent responses and the lifespan of B cells
Otipoby, K. L., Andersson, K. B., Draves, K. E., Klaus, S. J., Farr, A. G., Kerner, J. D., Perlmutter, R. M., Law, C.-L., & Clark, E. A. (1996) · Nature · doi:10.1038/384634a0 · Cited by 390
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan, C., Shi, Y., Laman, J. D., & Datta, S. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1470 · Cited by 364
Kazatchkine, M. D., Fearon, D. T., & Kf, A. (1979) · PubMed · Cited by 350
Lupus susceptibility loci in New Zealand mice.
Kono, D. H., Burlingame, R. W., Owens, D. G., Kuramochi, A., Balderas, R. S., Balomenos, D., & Theofilopoulos, A. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10168 · Cited by 344
GENETIC SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUS
Vyse, T. J., & Kotzin, B. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.261 · Cited by 313
Kazatchkine, M. D., Fearon, D. T., & Austen, K. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.1.75 · Cited by 290
Inhibition of the B Cell by CD22: A Requirement for Lyn
Smith, K. G. C., Tarlinton, D. M., Doody, G. M., Hibbs, M. L., & Fearon, D. T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.807 · Cited by 261
Functional dissection of systemic lupus erythematosus using congenic mouse strains
Morel, L., Mohan, C., Yu, Y., Croker, B. P., Tian, N., Deng, A., & Wakeland, E. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.6019 · Cited by 260
Pani, G., Kozlowski, M., Cambier, J. C., Mills, G. B., & Siminovitch, K. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2077 · Cited by 251
Mohan, C., Morel, L., Yang, P., & Wakeland, E. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.454 · Cited by 224
Powell, L. D., Sgroi, D., Sjoberg, E. R., Stamenkovic, I., & Varki, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53140-9 · Cited by 216
A Double-Edged Kinase Lyn: A Positive and Negative Regulator for Antigen Receptor–mediated Signals
Nishizumi, H., Horikawa, K., Mlinaric-Rascan, I., & Yamamoto, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1343 · Cited by 199
Inaoki, M., Sato, S., Weintraub, B. C., Goodnow, C. C., & Tedder, T. F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1923 · Cited by 193
Sobel, E. S., Katagiri, T., Katagiri, K., Morris, S. C., Cohen, P. L., & Eisenberg, R. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1441 · Cited by 193
CD22 associates with the human surface IgM-B-cell antigen receptor complex.
Leprince, C., Draves, K. E., Geahlen, R. L., Ledbetter, J. A., & Clark, E. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3236 · Cited by 181
Shultz, L. D., & Green, M. C. (1976) · PubMed · Cited by 174
Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes
Chan, V. W. F., Lowell, C. A., & DeFranco, A. L. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70223-4 · Cited by 173
Dörken, B., Moldenhauer, G., Pezzutto, A., Schwartz, R., Feller, A., Kiesel, S., & Nadler, L. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4470 · Cited by 170
Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice.
Drake, C. G., Babcock, S. K., Palmer, E., & Kotzin, B. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4062 · Cited by 166
Association of CD22 with the B cell antigen receptor
Peaker, C. J. G., & Neuberger, M. S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230626 · Cited by 154
Self-citationMultiple Lupus Susceptibility Loci Map to Chromosome 1 in BXSB Mice
Hogarth, M. B., Slingsby, J. H., Allen, P. J., Thompson, E. M., Chandler, P., Davies, K. A., Simpson, E., Morley, B. J., & Walport, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2753 · Cited by 126
Phosphotyrosine‐dependent association between CD22 and protein tyrosine phosphatase 1C
Campbell, M., & Klinman, N. R. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250616 · Cited by 121
Motheaten, an Immunodeficient Mutant of the Mouse
Shultz, L. D., & Green, M. C. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.116.4.936 · Cited by 104
Sater, R. A. (1998) · International Immunology · doi:10.1093/intimm/10.11.1673 · Cited by 89
B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines
Nadler, M. J. S., McLean, P. A., Neel, B. G., & Wortis, H. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4233 · Cited by 46
Rapid cloning of any rearranged mouse immunoglobulin variable genes
Dattamajumdar, A. K., Jacobson, D. P., Le, H., & Osman, G. E. (1996) · Immunogenetics · doi:10.1007/bf00176675 · Cited by 33
Sequences of four new members of the V H7183 gene family in BALB/c mice
Chukwuocha, R. U., Hartman, A. B., & Feeney, A. J. (1994) · Immunogenetics · doi:10.1007/bf00163968 · Cited by 21
Cited by
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Metadata
- Authors
- O'Keefe, T. L., Williams, G. T., Batista, F. D., & Neuberger, M. S.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-04-19
- Volume
- 189
- Issue
- 8
- Pages
- 1307-1313
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2156772263
- Cited by
- 320
- References
- 40
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.